E-LIB Suche - Ergebnisse für: Deininger, Michael W

1

A Bayesian framework to study tumor subclone–specific expre..:

Qiao, Yi ; Huang, Xiaomeng ; Moos, Philip J....
Genome Research. 34 (2024) 1 - p. 94-105 , 2024

Link: https://doi.org/10.1101/..

2

Beat-AML 2024 ELN-Refined Risk Stratification for Older Adu..:

Hoff, Fieke W ; Blum, William ; Huang, Ying...
Blood Advances. , 2024

Link: https://doi.org/10.1182/..

3

Comparison of colorimetric, fluorometric, and liquid chroma..:

Kantner, Daniel S. ; Megill, Emily ; Bostwick, Anna...
Analytical Biochemistry. 685 (2024) - p. 115405 , 2024

Link: https://doi.org/10.1016/..

4

MPN-295 Avapritinib in Patients With Advanced Systemic Mast..:

Gotlib, Jason ; Reiter, Andreas ; Radia, Deepti H....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S388-S389 , 2023

Link: https://doi.org/10.1016/..

5

POSTER: MPN-295 Avapritinib in Patients With Advanced Syste..:

Gotlib, Jason ; Reiter, Andreas ; Radia, Deepti H....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S193 , 2023

Link: https://doi.org/10.1016/..

6

Mapping the Evidence for Opioid-Mediated Changes in Maligna..:

Constance, Jonathan E ; McFarland, Mary M ; Casucci, Tallie...
JMIR Research Protocols. 12 (2023) - p. e38167 , 2023

Link: https://doi.org/10.2196/..

7

In vitro evidence of synergistic efficacy with asciminib co..:

Han, Ho-Jae ; Kim, Jaeyoon John ; Pyne, Danielle...
Leukemia. 38 (2023) 2 - p. 412-415 , 2023

Link: https://doi.org/10.1038/..

8

Population modeling of bosutinib exposure‐response in patie..:

Garrett, May ; Knight, Beverly ; Cortes, Jorge E..
Cancer Medicine. 12 (2023) 17 - p. 17981-17992 , 2023

Link: https://doi.org/10.1002/..

9

CML-413 Efficacy and Safety of Bosutinib Versus Imatinib in..:

Kota, Vamsi ; Deininger, Michael W. ; Mendler, Jason...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S296-S297 , 2022

Link: https://doi.org/10.1016/..

10

Efficacy and safety of avapritinib in previously treated pa..:

Reiter, Andreas ; Schwaab, Juliana ; DeAngelo, Daniel J....
Blood Advances. 6 (2022) 21 - p. 5750-5762 , 2022

Link: https://doi.org/10.1182/..

11

Long-term safety review of tyrosine kinase inhibitors in ch..:

Lipton, Jeffrey H. ; Brümmendorf, Tim H. ; Gambacorti-Passerini, Carlo...
Blood Reviews. 56 (2022) - p. 100968 , 2022

Link: https://doi.org/10.1016/..

12

Bosutinib versus imatinib for newly diagnosed chronic phase..:

Brümmendorf, Tim H. ; Cortes, Jorge E. ; Milojkovic, Dragana...
Leukemia. 36 (2022) 7 - p. 1825-1833 , 2022

Link: https://doi.org/10.1038/..

13

MS4A3 promotes differentiation in chronic myeloid leukemia ..:

Zhao, Helong ; Pomicter, Anthony D. ; Eiring, Anna M....
Blood. 139 (2022) 5 - p. 761-778 , 2022

Link: https://doi.org/10.1182/..

14

Poster: CML-413 Efficacy and Safety of Bosutinib Versus Ima..:

Kota, BFORE Trial Vamsi ; Deininger, Michael W. ; Mendler, Jason...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S145 , 2022

Link: https://doi.org/10.1016/..

15

MPN-395: Efficacy and Safety of ≤200 mg Avapritinib in Pati..:

Radia, Deepti ; DeAngelo, Daniel ; Deininger, Michael W....
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S367-S368 , 2021

Link: https://doi.org/10.1016/..